Literature DB >> 10822129

Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma.

M Puzianowska-Kuznicka1, A Nauman, A Madej, Z Tanski, S Cheng, J Nauman.   

Abstract

Human renal clear cell carcinoma (RCCC) accounts for up to 2% of human cancers. To find out if thyroid hormone (T3) and its receptors (TRs) play a role in tumorigenesis of RCCC, the expression of TRs was evaluated on mRNA and protein level. It was found that TRalpha (both alpha1 and alpha2) mRNA amount was significantly decreased in tumors while compared with healthy kidney tissue, and this decrease was deepest in G1 (well differentiated) RCCCs. In contrast, TRalpha1 protein was 1.6x overexpressed in tumors. TRbeta1 mRNA amount was overexpressed in 30% and significantly decreased in 70% of examined tumors. On the protein level, TRbeta1 amount was 1.7x lower in tumors than in healthy controls.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822129     DOI: 10.1016/s0304-3835(00)00416-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation.

Authors:  L D Miller; K S Park; Q M Guo; N W Alkharouf; R L Malek; N H Lee; E T Liu; S Y Cheng
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 2.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

Review 3.  Genetic features of thyroid hormone receptors.

Authors:  Maha Rebaï; Imen Kallel; Ahmed Rebaï
Journal:  J Genet       Date:  2012       Impact factor: 1.166

Review 4.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

5.  A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation.

Authors:  Ivan H Chan; Martin L Privalsky
Journal:  Mol Cancer Res       Date:  2010-01-06       Impact factor: 5.852

6.  Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.

Authors:  Sara Karami; Paul Brennan; Philip S Rosenberg; Marie Navratilova; Dana Mates; David Zaridze; Vladimir Janout; Helena Kollarova; Vladimir Bencko; Vsevolod Matveev; Neonila Szeszenia-Dabrowska; Ivana Holcatova; Meredith Yeager; Stephen Chanock; Idan Menashe; Nathaniel Rothman; Wong-Ho Chow; Paolo Boffetta; Lee E Moore
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

7.  A case of resistance to thyroid hormone with thyroid cancer.

Authors:  Hee Kyung Kim; Doi Kim; Eun Hyung Yoo; Ji In Lee; Hye Won Jang; Alice Hyun Kyung Tan; Kyu Yeon Hur; Jae Hyeon Kim; Kwang-Won Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  J Korean Med Sci       Date:  2010-08-12       Impact factor: 2.153

8.  Novel oncogenic actions of TRbeta mutants in tumorigenesis.

Authors:  Celine J Guigon; Sheue-yann Cheng
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

9.  Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.

Authors:  X-G Zhu; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

10.  Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Won Gu Kim; Li Zhao; Dong Wook Kim; Mark C Willingham; Sheue-yann Cheng
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.